US EditionParker Waichman LLP Files One of the First NAION Eye Injury Cases against Novo Nordisk in the Superior Court of New Jersey, Middlesex County
- Parker Waichman LLP filed a lawsuit against Novo Nordisk in New Jersey on April 15, 2025.
- The lawsuit was filed after a plaintiff developed NAION, linked to semaglutide drugs.
- Semaglutide, found in Ozempic and Wegovy, has been connected to optic nerve disorders like NAION.
- Jason S. Goldstein stated NAION is a devastating eye injury; Novo Nordisk must be accountable.
- Affected individuals may seek a free case review from Parker Waichman LLP for potential compensation.
Insights by Ground AI
Does this summary seem wrong?
54 Articles
54 Articles
All
Left
4
Center
14
Right
5
Bennington Banner+53 Reposted by 53 other sources
Parker Waichman LLP Files One of the First NAION Eye Injury Cases against Novo Nordisk in the Superior Court of New Jersey, Middlesex County
PORT WASHINGTON, N.Y., April 15, 2025 /PRNewswire/ -- Parker Waichman LLP, a nationally recognized law firm dedicated to representing victims of defective drugs and devices, recently filed a lawsuit against Novo Nordisk on behalf of a New Jersey based Plaintiff…
Coverage Details
Total News Sources54
Leaning Left4Leaning Right5Center14Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 17%
C 61%
R 22%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
